Founded in 1953 in Hyderabad, Biological E. is a privately held Indian biopharmaceutical company specializing in vaccines, biologics, branded formulations, and injectable generics. A pioneer in affordable vaccine production, BE was the first private sector vaccine manufacturer in India and now serves global public health initiatives with over 9 WHO‑prequalified vaccines and widespread presence across branded and injectable therapies. The company supplies to more than 100 countries and has delivered more than 2 billion vaccine doses globally.
Company CEO / Managing Director
Mahima Datla serves as Managing Director & CEO, overseeing vaccines and branded formulations.
Vaccines & Biologics: Maker of DPT, Pentavalent, Corbevax, JE, Pneumococcal vaccines; largest global tetanus vaccine producer.
Specialty Generic Injectables: Developed through BE Pharmaceuticals; focused on non-biological complex drugs and regulated markets. U.S. operations based in Cary, North Carolina.
Branded Formulations: Includes products like Heparin, Noscapine‑based cough medicines, Enoxaparin APIs, and a wide therapeutic portfolio for domestic and institutional markets.
Location / Headquarters
Road No. 35, Jubilee Hills, Hyderabad, Telangana, 500033, India
